Subbu Nambi
Stock Analyst at Guggenheim
(2.67)
# 2,057
Out of 4,711 analysts
22
Total ratings
50%
Success rate
6.06%
Average return
Main Sectors:
Stocks Rated by Subbu Nambi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NEOG Neogen | Initiates: Buy | $15 | $12.04 | +24.58% | 1 | Dec 19, 2024 | |
| BRKR Bruker | Initiates: Buy | $72 | $57.00 | +26.32% | 1 | Dec 19, 2024 | |
| TEM Tempus AI | Initiates: Buy | $74 | $35.54 | +108.22% | 1 | Dec 9, 2024 | |
| GRAL GRAIL | Initiates: Neutral | n/a | $18.35 | - | 1 | Oct 17, 2024 | |
| VCYT Veracyte | Initiates: Buy | $40 | $40.89 | -2.18% | 1 | Oct 10, 2024 | |
| GH Guardant Health | Upgrades: Buy | $36 | $31.67 | +13.67% | 3 | Jun 28, 2024 | |
| SOPH SOPHiA GENETICS | Initiates: Buy | $6 | $3.26 | +84.05% | 1 | Jun 27, 2024 | |
| NAUT Nautilus Biotechnology | Initiates: Buy | $6 | $1.76 | +240.91% | 1 | Jun 27, 2024 | |
| TXG 10x Genomics | Downgrades: Neutral | n/a | $14.04 | - | 3 | Jun 26, 2024 | |
| RGEN Repligen | Initiates: Neutral | n/a | $144.46 | - | 1 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $53 | $47.94 | +10.55% | 1 | Jun 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $25 | $27.53 | -9.19% | 1 | Dec 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $23 | $13.36 | +72.16% | 1 | Dec 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $70 | $161.88 | -56.76% | 1 | Dec 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $90 | $59.40 | +51.52% | 1 | Dec 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $1.97 | - | 1 | Dec 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $155 | $136.02 | +13.95% | 1 | Dec 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $2.49 | - | 1 | Dec 14, 2023 |
Neogen
Dec 19, 2024
Initiates: Buy
Price Target: $15
Current: $12.04
Upside: +24.58%
Bruker
Dec 19, 2024
Initiates: Buy
Price Target: $72
Current: $57.00
Upside: +26.32%
Tempus AI
Dec 9, 2024
Initiates: Buy
Price Target: $74
Current: $35.54
Upside: +108.22%
GRAIL
Oct 17, 2024
Initiates: Neutral
Price Target: n/a
Current: $18.35
Upside: -
Veracyte
Oct 10, 2024
Initiates: Buy
Price Target: $40
Current: $40.89
Upside: -2.18%
Guardant Health
Jun 28, 2024
Upgrades: Buy
Price Target: $36
Current: $31.67
Upside: +13.67%
SOPHiA GENETICS
Jun 27, 2024
Initiates: Buy
Price Target: $6
Current: $3.26
Upside: +84.05%
Nautilus Biotechnology
Jun 27, 2024
Initiates: Buy
Price Target: $6
Current: $1.76
Upside: +240.91%
10x Genomics
Jun 26, 2024
Downgrades: Neutral
Price Target: n/a
Current: $14.04
Upside: -
Repligen
Jun 18, 2024
Initiates: Neutral
Price Target: n/a
Current: $144.46
Upside: -
Jun 5, 2024
Initiates: Buy
Price Target: $53
Current: $47.94
Upside: +10.55%
Dec 14, 2023
Initiates: Buy
Price Target: $25
Current: $27.53
Upside: -9.19%
Dec 14, 2023
Initiates: Buy
Price Target: $23
Current: $13.36
Upside: +72.16%
Dec 14, 2023
Initiates: Buy
Price Target: $70
Current: $161.88
Upside: -56.76%
Dec 14, 2023
Initiates: Buy
Price Target: $90
Current: $59.40
Upside: +51.52%
Dec 14, 2023
Initiates: Neutral
Price Target: n/a
Current: $1.97
Upside: -
Dec 14, 2023
Initiates: Buy
Price Target: $155
Current: $136.02
Upside: +13.95%
Dec 14, 2023
Initiates: Neutral
Price Target: n/a
Current: $2.49
Upside: -